CD8A and neoplasm: In a recent publication (100) it was shown that the acidic pH in the tumor interferes with the binding of native IL-2 to CD25, resulting in reduced STAT5 phosphorylation, effector differentiation, and antitumor immunity by CD8+ T cells.